KR950704353A - Hepatitis C Viral (HCV) Non-Struct-3 Peptides, Antibodies To It, and Methods for Detecting HCV (HCV) NON-STRUCTURAC-3 PEPTIDES DETECTION OF HCV - Google Patents
Hepatitis C Viral (HCV) Non-Struct-3 Peptides, Antibodies To It, and Methods for Detecting HCV (HCV) NON-STRUCTURAC-3 PEPTIDES DETECTION OF HCVInfo
- Publication number
- KR950704353A KR950704353A KR1019950702373A KR19950702373A KR950704353A KR 950704353 A KR950704353 A KR 950704353A KR 1019950702373 A KR1019950702373 A KR 1019950702373A KR 19950702373 A KR19950702373 A KR 19950702373A KR 950704353 A KR950704353 A KR 950704353A
- Authority
- KR
- South Korea
- Prior art keywords
- hcv
- peptide
- detecting
- hepatitis
- test fluid
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 11
- 238000000034 method Methods 0.000 title claims abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 4
- 208000005176 Hepatitis C Diseases 0.000 title claims 2
- 238000001514 detection method Methods 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 108700023195 montirelin Proteins 0.000 claims abstract 5
- 239000000427 antigen Substances 0.000 claims abstract 3
- 102000036639 antigens Human genes 0.000 claims abstract 3
- 108091007433 antigens Proteins 0.000 claims abstract 3
- 239000012530 fluid Substances 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 241000711549 Hepacivirus C Species 0.000 claims 3
- 150000007523 nucleic acids Chemical group 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000000984 immunochemical effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
본 발명은 HCV에 대해 유도된 항체와 면역화학적으로 반응성인 펨티드에 관한 것이다. 본 발명에 따른 바람직한 펩티드는 NS-3단백질의 HCV특이성 에피토프를 함유한다. 추가로 본 발명은 HCV의 NS-3 단백질과 특이정이로 반응성인 항체에 관한 것이다. HCV또는 HCV 항체의 검출방법 및 NS-3항원과 특이적으로 반응성인 항체의 검출방법 또는 본 발명의 일부이다.The present invention relates to femtides immunochemically reactive with antibodies induced against HCV. Preferred peptides according to the invention contain HCV-specific epitopes of the NS-3 protein. The present invention further relates to antibodies which are specifically reactive with NS-3 protein of HCV. Methods of detecting HCV or HCV antibodies and methods of detecting antibodies specifically reactive with NS-3 antigens or as part of the present invention.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.
Claims (12)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92203802 | 1992-12-07 | ||
EP92203802.1 | 1993-06-25 | ||
PCT/EP1993/003422 WO1994013699A1 (en) | 1992-12-07 | 1993-12-06 | Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950704353A true KR950704353A (en) | 1995-11-20 |
Family
ID=8211111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950702373A KR950704353A (en) | 1992-12-07 | 1993-12-06 | Hepatitis C Viral (HCV) Non-Struct-3 Peptides, Antibodies To It, and Methods for Detecting HCV (HCV) NON-STRUCTURAC-3 PEPTIDES DETECTION OF HCV |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0672065A1 (en) |
JP (1) | JPH08505131A (en) |
KR (1) | KR950704353A (en) |
AU (1) | AU6653394A (en) |
CA (1) | CA2151128A1 (en) |
FI (1) | FI952778A (en) |
WO (1) | WO1994013699A1 (en) |
ZA (1) | ZA939169B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2294690B (en) * | 1994-11-01 | 1998-10-28 | United Biomedical Inc | Peptides effective for diagnosis and detection of hepatitis C infection |
EP1195381A1 (en) | 2000-09-28 | 2002-04-10 | Immusystems GmbH | Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE318216T1 (en) * | 1987-11-18 | 1990-06-13 | Chiron Corp., Emeryville, Calif., Us | NANBV DIAGNOSTICS AND VACCINE. |
-
1993
- 1993-12-06 AU AU66533/94A patent/AU6653394A/en not_active Abandoned
- 1993-12-06 EP EP94903750A patent/EP0672065A1/en not_active Withdrawn
- 1993-12-06 CA CA002151128A patent/CA2151128A1/en not_active Abandoned
- 1993-12-06 WO PCT/EP1993/003422 patent/WO1994013699A1/en not_active Application Discontinuation
- 1993-12-06 KR KR1019950702373A patent/KR950704353A/en not_active Application Discontinuation
- 1993-12-06 JP JP6513756A patent/JPH08505131A/en active Pending
- 1993-12-07 ZA ZA939169A patent/ZA939169B/en unknown
-
1995
- 1995-06-06 FI FI952778A patent/FI952778A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0672065A1 (en) | 1995-09-20 |
CA2151128A1 (en) | 1994-06-23 |
FI952778A0 (en) | 1995-06-06 |
WO1994013699A1 (en) | 1994-06-23 |
JPH08505131A (en) | 1996-06-04 |
FI952778A (en) | 1995-07-19 |
AU6653394A (en) | 1994-07-04 |
ZA939169B (en) | 1994-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930019829A (en) | Peptide and Nucleic Acid Sequences Associated with Epstein Barr Virus | |
ATE144993T1 (en) | SYNTHETIC ANTIGENS FOR DETECTING ANTIBODIES AGAINST HEPATITIS C VIRUS | |
KR930004055B1 (en) | Peptide and its use | |
US5229491A (en) | Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus | |
EP0696640A3 (en) | Recombinant antigen from the NS3 region of Hepatitis C virus | |
CA2049679A1 (en) | Hepatitis c assay utilizing recombinant antigens | |
DE69230812T2 (en) | Method for the detection of a bovine diarrhea virus infection, for a nucleotide sequence coding for an infection induced by this virus, and recombinant proteins and antigens derived therefrom | |
KR930008155A (en) | Monoclonal Antibodies Against Hepatitis Hepatitis Virus (HCV) | |
US20030108563A1 (en) | Reagents for the simultaneous detection of HCV core antigens and antibodies | |
KR950704353A (en) | Hepatitis C Viral (HCV) Non-Struct-3 Peptides, Antibodies To It, and Methods for Detecting HCV (HCV) NON-STRUCTURAC-3 PEPTIDES DETECTION OF HCV | |
KR950704354A (en) | Peptides FROM THE C33 REGION OF HCV, ANTIBODIES THERETO AND METHODS FOR THE (C) Hepatitis Virus (HCV) DETECTION OF HCV | |
KR930004328A (en) | Non-A, Non-B Type Peptides | |
KR960034420A (en) | A multimeric antigen peptide consisting of at least two hepatitis C virus-related peptides | |
EP0536838A2 (en) | Non-A, non-B peptides | |
WO1993011158A2 (en) | Non-a, non-b peptides | |
KR960014341A (en) | Toxoplasma Gondi Antigen | |
JPH07502996A (en) | Peptide showing immunochemical reactivity with antibodies against non-A, non-B hepatitis viruses | |
KR930700551A (en) | Non-A, Non-B Sequences | |
Miyakawa et al. | Reactivity of sera from Japanese patients with type 2 autoimmune hepatitis to peptides derived from host genes, cytochrome HLD8-2 and GOR | |
EP1310512A2 (en) | Hcv core protein sequences | |
Semiletov et al. | Use of synthetic peptides as additional antigens for detecting antibodies to hepatitis C virus | |
KR930000127A (en) | Non-A Non-B Hepatitis Diagnosis Methods and Vaccines | |
CA2405849A1 (en) | Reagents for the simultaneous detection of hcv core antigens and antibodies | |
KR920002785A (en) | Nucleic acid fragments coding for non-A hepatitis B virus constituent peptide and uses thereof | |
JPH04221398A (en) | Antibody to non-a, non-b hepatitis virus and immunochemically reactive peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |